James Andersen - Accel Research Sites

Create a Profile

I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.
Create a Profile
I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.

Get In Touch Mobile

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location
Back
Date Published: 09/09/2022

James Andersen

Dr. James Andersen is a principal investigator at Accel Research Sites’ Lakeland location, specializing in family and addiction medicine. He has completed 226 clinical trials as a principal investigator. His experience in addiction studies includes opioid and cocaine use disorder, opioid-induced constipation, and smoking cessation. In addition, he is Suboxone-certified and has conducted trials evaluating buprenorphine and COVID-19 vaccines, including presenting at the FDA Sublocade Scientific Advisory Committee.

Dr. Andersen honed his addiction medicine capabilities during nearly two decades as medical director of Polk County’s first Opioid Treatment Program. Additionally, he served as medical director for two facilities operated by Bridges of America. Dr. Andersen is a Fellow in the American Society of Addition Medicine and a Diplomate with the American Board of Addiction Medicine. He is a former medical review officer, AAMRO, and diplomate, emeritus, of the American Board of Family Practice. He also formerly served for two, three-year terms as director of the Florida Academy of Family Physicians.

Back

Ready to be part of healthcare history? Find the right clinical trial for you.

Get In Touch

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.
Accessibility Adjustment

Color Adjustment

Orientation Adjustment

Font Size

 

Line height